To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

DIABETES PREVENTION

TODAY'S HEADLINES

Diabetes program saves thousands of dollars

A YMCA diabetes prevention program has been so successful that the Obama administration is planning to offer it to all Medicare members in 2017. Read more

First generic Nasonex available

FDA recently approved the first generic version of Nasonex nasal spray (mometasone furoate monohydrate, Apotex Corp). When it's available

CONTINUING PHARMACY EDUCATION

Part 2: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose

This month's CE activity is open for pharmacists and pharmacy technicians. "Part II: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Biosimilars' savings may reach $100 billion by 2020

The use of biosimilars in the European Union and the United States may yield total savings of $56 billion to $110 billion over the next five years, according to a new report. Read more

April 06, 2016

Related Articles

FDA approves long-acting insulin drugs

First nasal spray helps with drug overdoses

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us